RNA-seq of human breast cancer cell lines characterized by ERalpha-LBD overexpression or knockdown, compared to control cells (with or without fulvestrant treatment). RNA-seq of human breast cancer cell lines characterized by ERalpha-LBD overexpression or knockdown, compared to control cells (with or without fulvestrant treatment)

RNA-seq analysis was carried out to study the effect on transcriptome of ERalpha-LDB gain/loss-of-function in different breast cancer models. Total RNA was extracted and processed for the analysis.